The Indian Competition Authority dismisses allegations of abuse of dominance against a pharmaceutical manufacturer due to lack of evidence of dominance (Sanofi)

Sharma, Man Mohan

Previous article The Indian Competition Authority dismisses allegations of abuse of dominance against a company in the market for radio taxi services and holds that a high market share does not in and of itself constitute dominance (Fast Track Call Cab / ANI Technologies / OLA Cabs) Next article The Indian Competition Authority opens its third investigation in a short amount of time into the abuse of dominance by one of the largest national energy companies (Mohan Meakin / Gail India)

19 Jul 2017

The Indian Competition Authority dismisses allegations of abuse of dominance against a pharmaceutical manufacturer due to lack of evidence of dominance (Sanofi)

KEYWORDS

Reference

Indian Competition Authority, Sanofi, Case No. 80/2016, 19 July 2017

CCI closes allegation of abuse of dominance against Sanofi* CCI vide its order dated July 19, 2017 has closed an allegation of abuse of dominant position against Sanofi India Limited (Sanofi). The Informant in the case sought confidentiality of his identity and hence was not named. The Informant

Access to this article is restricted to subscribers

Already Subscribed? Sign-in

Access to this article is restricted to subscribers.

Read one article for free

Sign-up to read this article for free and discover our services.

PDF Version

Author

Man Mohan Sharma
Vaish Associates Advocates (New Delhi)

India 263 contributions 41104 visits

Quotation

Man Mohan Sharma, The Indian Competition Authority dismisses allegations of abuse of dominance against a pharmaceutical manufacturer due to lack of evidence of dominance (Sanofi), 19 July 2017, e-Competitions July 2017, Art. N° 87531

Visites 252